Related Experiment Video
Updated: Jul 5, 2025

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.6K
Developing a community-led rare disease ELSI research agenda
Courtney Berrios1,2, Macy McBeth3, Andrea Bradley-Ewing4
1Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO, USA. cdberrios@cmh.edu.
Orphanet Journal of Rare Diseases
|January 23, 2024
Summary
Community stakeholders co-created a pediatric rare disease research agenda. This patient-centered approach prioritized ethical, legal, and social implications (ELSI) research based on lived experiences, ensuring alignment with family needs.
Area of Science:
- Pediatric rare disease research
- Community-engaged research
- Ethical, Legal, and Social Implications (ELSI) studies
Background:
- Community engagement is crucial for defining research priorities, especially for rare diseases.
- A pediatric rare disease community stakeholder group was established to elicit family perspectives.
- The goal was to synthesize ideas into a research agenda focused on shared ELSI concerns.
Purpose of the Study:
- To establish a pediatric rare disease community stakeholder group.
- To empower this group in eliciting and synthesizing perspectives from affected families.
- To develop a research agenda focused on shared ELSI across rare diseases.
Main Methods:
- A two-year community-centered approach involved rare disease community members as equal partners.
- A 22-member stakeholder group, "Rare Voices" (RV), comprising patients, parents, clinicians, and researchers was formed.
- RV conducted listening sessions with patients and parents, synthesized findings, and prioritized research topics after capacity-building training.
Main Results:
- Fourteen listening sessions engaged 52 parents and 13 teen patients.
- Eight core research topics were identified: care coordination, communication, resource access, family impact, community support, mental health, ethical aspects, and uncertainty.
- RV members reported high engagement and satisfaction with the process and the resulting research agenda.
Conclusions:
- A community-led rare disease research agenda was developed through capacity-building and authentic engagement.
- The agenda aligns with patient and family priorities for future rare disease ELSI research.
- Equal partnership fostered mutual learning and empowered community members to shape research based on lived experiences.
Related Concept Videos
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K

